Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/28419
DC FieldValueLanguage
dc.contributor.authorNikolova, Sonjaen_US
dc.date.accessioned2023-11-13T08:25:45Z-
dc.date.available2023-11-13T08:25:45Z-
dc.date.issued2023-11-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/28419-
dc.description.abstractRegardless of the colossal efforts in lung cancer treatment, the majority of patients will present at an advanced stage when any curative treatment will no longer be an option. The overall 5-year survival for all tumor stages is disturbingly low at 15%, and lung cancer is the leading cause of cancer-related deaths for both genders worldwide. Early diagnosis as well as appropriate radiological staging is of utter importance for patients with early-stage lung cancer that can greatly benefit from timely treatment. The current 8th revision of tumor, node, metastasis (TNM) staging system accepted by The International Association for the Study of Lung Cancer (IASLC) and the American Joint Committee on Cancer (AJCC) was published in January, 2017, and the edition has committed some major alternations, including modification of the T classification based on 1 cm increment, down staging of the T descriptor disregarding its distance from carina (T2), integrating total and partial atelectasis/pneumonitis into the same T category (T2), upstaging diaphragmatic invasion to T4, new classification concepts of adenocarcinoma in situ and minimally invasive adenocarcinoma for pure and part-solid ground-glass nodules, and further division of extra thoracic metastasis into M1b and M1c based on their number and location. There is an agreement for some ambiguous conditions, such as the classification of Pancoast tumor based on its invasion depth, as well as categorization of various sites of pulmonary involvement. The IASLC Staging Project has provided evidence based recommendations for the TNM Classification for Thoracic Cancers in the last 20 years. The upgraded 9th edition of the TNM will be published on January 1, 2024 and will consider new data elements, including genetic biomarkers, protein alterations, and copy number alterations. In order for a radiologist to present an accurate clinical stage of lung cancer using consistent standards introduced in the 8th edition of the TNM Lung Cancer Staging System, it is important to acknowledge the prospective difficulties and limitations of imaging interpretation.en_US
dc.language.isoenen_US
dc.subjectTNM stageen_US
dc.subjectlung canceren_US
dc.subjectT descriptoren_US
dc.subjectN descriptoren_US
dc.subjectM descriptoren_US
dc.titleCurrent concepts in CT Diagnosis and TNM-8 staging of Lung Canceren_US
dc.typeProceeding articleen_US
dc.relation.conference7th Macedonian National Congress of Radiologyen_US
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
7th Macedonian NationalCongress of Radiology, Sonja Nikolova.pdf4.08 MBAdobe PDFView/Open
Show simple item record

Page view(s)

51
checked on Jul 18, 2024

Download(s)

20
checked on Jul 18, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.